ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,159.10
-0.92%
S&P ASX All Technology
3,805.40
-1.15%
Brent Oil
74.565
0.63%
US Dollar vs AUD
1.61055
0.16%
Bitcoin
92,711.61
0.05%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Upstream Bio Inc (UPB) Share Price

Upstream Bio Inc

Upstream Bio Inc (UPB)

NASDAQ
17.12
-2.07
(-10.79%)
Closed 31 December 8:00AM
Delayed by 15 minutes
17.60
0.48
(2.80%)
After Hours: 10:49AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
17.60
Bid
16.10
Offer
22.25
Volume
232,154
16.825 Day's Range 18.70
14.97 52 Week Range 29.30
Previous Close
19.19
Open
18.70
Last Trade
1
@
17.4
Last Trade Time
Average Volume (3m)
375,255
Financial Volume
US$ 4,080,251
VWAP
17.5756

Ask ADVFN Intelligence (AI)

UPB Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

18 December 2024
Edgar (US Regulatory)

Upstream Bio Appoints Allison Ambrose as General Counsel

WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

18 December 2024
GlobeNewswire Inc.

Upstream Bio Announces Addition to Russell 2000® Index

WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

17 December 2024
GlobeNewswire Inc.

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...

22 November 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 November 2024
Edgar (US Regulatory)

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...

07 November 2024
GlobeNewswire Inc.

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

23 October 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

16 October 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.539.5208462974516.0720.16815.90517286718.87137546CS
4-4.1-18.894009216621.724.97514.9747572318.27029362CS
12-3.9-18.139534883721.529.314.9737525521.24923508CS
26-3.9-18.139534883721.529.314.9737525521.24923508CS
52-3.9-18.139534883721.529.314.9737525521.24923508CS
156-3.9-18.139534883721.529.314.9737525521.24923508CS
260-3.9-18.139534883721.529.314.9737525521.24923508CS

UPB - Frequently Asked Questions (FAQ)

What is the current Upstream Bio share price?
The current share price of Upstream Bio is US$ 17.60
What is the 1 year trading range for Upstream Bio share price?
Upstream Bio has traded in the range of US$ 14.97 to US$ 29.30 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WATTEnergous Corporation
US$ 2.70
(556.61%)
226.21M
NXUNXU Inc
US$ 1.52
(524.49%)
572.73M
HOLOMicroCloud Hologram Inc
US$ 6.40
(166.67%)
221.85M
INTZIntrusion Inc
US$ 5.67
(162.50%)
132.97M
SMXSMX Security Matters Public Company
US$ 0.803558
(127.25%)
370.63M
ICGIntchains Group Ltd
US$ 3.39
(-63.67%)
1.77M
ABPAbpro Holdings Inc
US$ 2.10
(-53.23%)
2.17M
LITMSnow Lake Resources Ltd
US$ 0.9212
(-42.43%)
69.28M
TRAWTraws Pharma Inc
US$ 8.33
(-37.93%)
1.2M
BDMDBaird Medical Investment Holdings Ltd
US$ 1.07
(-37.79%)
153.54k
NXUNXU Inc
US$ 1.52
(524.49%)
572.73M
SMXSMX Security Matters Public Company
US$ 0.803558
(127.25%)
370.63M
VINCVincerx Inc
US$ 0.3243
(67.16%)
335.59M
XTIAXTI Aerospace Inc
US$ 0.0395
(0.00%)
292.67M
WATTEnergous Corporation
US$ 2.70
(556.61%)
226.21M

Discussion

View Full Feed
Double DD Double DD 15 minutes ago
Are the tax sellers all done,, let's go igpk!!
IGPK
stockstobuy stockstobuy 16 minutes ago
The fact that they think the $11Bil revenue is also an asset just tell you something about this scam. At least other OTC scams are being run by smart people but this trash is being run by really stupid people headed by the veteran ringleader scammer James Tilton. Just like telling the shareholders i
NSAV
pennypop pennypop 16 minutes ago
At least a decent suit after all this🤷‍♂️😉
HDVY
CrashOverride CrashOverride 19 minutes ago
Wrong again Jerry!

1. "Long tail is an interesting point. Once again, it ties back to advantages in resection, KPS, etc."

Why It’s Wrong:

Randomization Accounts for Baseline Differences: The DCVax-L trial was a randomized controlled trial (RCT), and rando
NWBO
Golden Cross Golden Cross 20 minutes ago
$ILLR Triller subsidiary BKFC is doing a long term partnership with Conor McGregor!
https://mmafighting.com/2024/4/28/24143313/conor-mcgregor-mcgregor-sports-and-entertainment-becomes-part-owner-of-bkfc
TORVF
Golden Cross Golden Cross 21 minutes ago
$ILLR ✨BKFC is the next UFC💫 Triller is majority owner of BKFC 🚀
https://youtube.com/watch?v=0a12NVei5E0

[yt]0a12NVei5E0[/yt]
TORVF
flipper44 flipper44 22 minutes ago
One year ago you stated you knew nothing about science, now you and your psychotic friends are trying any lame brained tactic.

People deserve to live without cancer pain and death Jerry.

Go find another stock to stab.

You really are stupid. You didn’
NWBO
Golden Cross Golden Cross 24 minutes ago
$ILLR x BKFC = GAME-CHANGER 🚀

Want to know how this could explode business growth?👀👇🎥 WATCH NOW:
https://youtube.com/watch?v=0a12NVei5E0
ILLR
Golden Cross Golden Cross 24 minutes ago
$ILLR x BKFC = GAME-CHANGER 🚀

Want to know how this could explode business growth?👀👇🎥 WATCH NOW:
https://youtube.com/watch?v=0a12NVei5E0
ILLR
weedtrader420 weedtrader420 25 minutes ago
WTF 🖕🤨🖕
XRPUSD
BakedLangostino BakedLangostino 35 minutes ago
If he's going to partner, he's going to partner when he knows the full potential of the company. He'll want insurance reimbursement for all the various CNS diseases for A273 and A371. The pain and cancer pipeline may be thrown in gratis as a sweetener for a deal to close. I think he'll also want to
AVXL
knrorrel knrorrel 36 minutes ago
QMMM very well closed a/h ....good sign
QMMM
THEBEASTMUGABI THEBEASTMUGABI 37 minutes ago
So what's happening with wimi in the morning fellas ?!
WIMI
knrorrel knrorrel 37 minutes ago
QMMM SHOULD RUNNING LIKE WIMI TO $3 OR MANY MORE

MAYBE LIKE QBTS

WE WE'LL SEE

imho
QBTS QMMM WIMI
knrorrel knrorrel 39 minutes ago
nice AI/ Quantum stock
QMMM
knrorrel knrorrel 39 minutes ago
very well closed a/h ....good sign
QMMM
Steady_T Steady_T 41 minutes ago
Merck didn't "give" $500M to a Chinese company. They got something in return which you fail to mention. What it 51% of the company? Was it rights to sell the treatment in the US. What was the quid pro quo?

All you can say is that is that Merck and NWBO have not arrived at a mutually a
NWBO
mrfence mrfence 42 minutes ago
When Bill Ackman Speaks,
https://i.imgflip.com/9f9nm4.jpg
The Horses are Coming so U Better RUN!
Bill Ackman expects U.S. President-elect Donald Trump to remove Fannie Mae (FNMA) and Freddie Mac (FREGP) from conservatorship,
https://finance.yahoo.com/news/bill-ackman
FMCC FNMA
wadegarret wadegarret 42 minutes ago
SS- AES

Stock does look cheap. Debt to equity a bit high though at about 4 to 1. I looked up SRE, and its debt to equity about 1.5 to 1. Both companies are listed as a diversified utility, but SRE has a 16 PE going forward, while AES only around a 6 PE going forward. Also the year
AES
BakedLangostino BakedLangostino 44 minutes ago
If it's a stock-for-stock buyout, Dr. Missling is going to have to be 100% convinced that their paper is better than our paper. Otherwise, it doesn't make much sense when looking at the potential upside. Better to just take on some debt or issue some more stock to fund an aggressive solo strategy:
AVXL
jhdf51 jhdf51 44 minutes ago
Same gibberish…zero result.

JHD
COOP
Steady_T Steady_T 50 minutes ago
And you base that prediction on what? Flaskworks won’t be approved commercially until second half of 2026 at the earliest. Take that to the bank!
NWBO
gp22 gp22 50 minutes ago
$BKYI: Bio-Key AI Inc.: Total shares 3.7M.
AI Drone & Autonomus Vehicle play. Exact match to $WKEY w/ much lower share count. Can make a $NUKK type move. Started getting hot on Monday. Likely a powerful move is underway. Heads up.
BKYI NUKK WKEY
gp22 gp22 50 minutes ago
$BKYI: Bio-Key AI Inc.: Total shares 3.7M.
AI Drone & Autonomus Vehicle play. Exact match to $WKEY w/ much lower share count. Can make a $NUKK type move. Started getting hot on Monday. Likely a powerful move is underway. Heads up.
BKYI NUKK WKEY

Your Recent History

NASDAQ
UPB
Upstream Bio
LSE
16FY
Investec Bnk 25
NASDAQ
CFHGX
Ci Mosaic Growth Etf Por...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads